Ophthalmic solution RU-101 contains the serum component albumin, which has shown to aid in the production of tears.
R-Tech Ueno hopes to gain marketing approval for the treatment soon.
More Articles on Ophthalmology:
Pharm, Olam, InSite Vision Complete Phase 3 Clinical Study
Study Finds 65% of Liver Transplant Patients Develop AMD
Glaucoma Management Lens to be Presented at ARVO 2013
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
